This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: CCL, DO, ORCL, MU, ZNGA

Stocks in this article: AKS B CCL DO ORCL MU ZNGA PCAR

Diamond Offshore (DO) estimates cut at Guggenheim through 2013, Guggenheim said. Recent fleet status suggested potentially lower utilization rates. Buy rating and $77 price target.

IHS (IHS) estimates, target raised at Credit Suisse. Shares of IHS now seen reaching $113, according to Credit Suisse. Estimates also increased, given the company's new guidance. Outperform rating.

Jabil Circuit (JBL) numbers cut at Citigroup. Shares of JBL now seen reaching $21, Citigroup said. Estimates also lowered on disappointing outlooks from major customers. Neutral rating.

Micron (MU) estimates cut at Credit Suisse through 2013, Credit Suisse said. Expect lower memory pricing. Outperform rating and $12 price target.

Oracle (ORCL) numbers raised at Jefferies. Shares of ORCL now seen reaching $32, Jefferies said. Estimates also raised on lower forecast tax rate. Hold rating.

Oracle estimates increased at Citigroup through 2014, Citigroup said. Guidance looks reasonable given macro and currency backdrop. Buy rating and $34 price target.

Paccar (PCAR) estimates, target lowered at Credit Suisse. Shares of PCAR now seen reaching $47, according to Credit Suisse. Estimates also cut, given reduced domestic truck orders. Neutral rating.

PerkinElmer (PKI) added to Conviction Buy List at Goldman. PKI was placed on the Conviction Buy list, Goldman Sachs said. Company is expanding margins and offers growth at an attractive price. $34 price target.

TIBCO Software (TBX) numbers lowered at Jefferies. Shares of TIBX now seen reaching $36, Jefferies said. Estimates also lowered on slower EMEA demand. Buy rating.

Watson Pharmaceuticals (WPI) added to Conviction Buy List at Goldman. Company offers the highest growth in the generics space. $87 price target.

Zynga (ZNGA) estimates, target reduced at BofA/Merrill. Shares of ZNGA now seen reaching $7, according to Bank of America/Merrill Lynch. Estimates also cut, given slower sales growth. Neutral rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,914.55 +109.75 0.62%
S&P 500 2,075.76 +5.11 0.25%
NASDAQ 4,777.7890 +12.4090 0.26%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs